Affinity Asset Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Affinity Asset Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-100,000	Closed	-$9.29M	–	79
2021 Q4	$9.29M	Buy	+100,000	New	+$6.59M	3.38%	7

Affinity Asset Advisors's ARNA Position: Q1 2022 in Review

Affinity Asset Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 100,000 shares — an estimated $9.29M sold.

Affinity Asset Advisors first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $9.29M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.

Affinity Asset Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
Affinity Asset Advisors sold 100,000 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $9.29M.
Affinity Asset Advisors first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
Affinity Asset Advisors's Arena Pharmaceuticals Inc position peaked at $9.29M in Q4 2021.
1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.

Based on Affinity Asset Advisors's 13F filing for Q1 2022, filed 13 May 2022.